Saflufenacil | CAS 372137-35-4 - Request Quote
Saflufenacil
| SZ CAT No: | SZ-S111001 |
| CAS No | 372137-35-4 |
| Mol.F. | C17H17ClF4N4O5S |
| Mol.Wt. | 500.8 |
| Inv. Status | Synthesis on demand |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Saflufenacil is chemically 2-Chloro-4-fluoro-N-(N-isopropyl-N-methylsulfamoyl)-5-(3-methyl-2,6-dioxo-4-(trifluoromethyl)-3,6-dihydropyrimidin-1(2H)-yl)benzamide. Saflufenacil is supplied with detailed characterization data compliant with regulatory guideline. Saflufenacil can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Saflufenacil.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 372137-35-4
Purchase 372137-35-4
Order 372137-35-4
Enquire 372137-35-4
price of 372137-35-4
372137-35-4 Supplier
372137-35-4 Manufacturer
372137-35-4 Exporter
buy high quality Saflufenacil
Purchase Saflufenacil
Saflufenacil suppliers
Saflufenacil manufacturers
Saflufenacil price
Order Saflufenacil
Enquire Saflufenacil
Saflufenacil cost
Saflufenacil Supplier
Saflufenacil Distributor
Saflufenacil for Method Validation
Saflufenacil Reference Standard
Saflufenacil for ANDA Filing
Saflufenacil for Forced Degradation Studies
Saflufenacil Identification Standards
Saflufenacil for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


